Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Diphtheria; Haemophilus Influenzae Type b Disease; Pertussis; Poliomyelitis; Tetanus
Interventions: Biological: Infanrix Hib™; Biological: Infanrix-IPV/Hib™; Biological: Poliorix™
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Rotavirus Gastroenteritis
Interventions: Biological: Placebo; Biological: Rotarix ™
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone furoate
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Placebo Inhalation Powder; Drug: Placebo Oral Capsule; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Prednisolone Oral Capsule; Drug: Fluticasone Furoate/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Chronic Migraine
Interventions: Drug: sumatriptan/naproxen sodium; Drug: Naproxen
Sponsors: Cady, Roger, M.D.; GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Compensated Chronic Hepatitis B
Interventions: Drug: lamivudine; Drug: lamivudine; Drug: lamivudine, adefovir
Sponsors: Nanfang Hospital; Ministry of Health, China; GlaxoSmithKline
Recruiting - verified March 2010
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK 1437173A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Workplace Migraine Treatment
Interventions: Drug: Usual prescribed triptan; Drug: Treximet for migraine treatment
Sponsors: The Cleveland Clinic; GlaxoSmithKline
Recruiting - verified September 2009
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Post-surgical Dental Pain
Interventions: Drug: Placebo; Drug: Paracetamol 1000 mg; Drug: Paracetamol 650 mg
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Fracture; Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure; Drug: Any Antiretroviral (ARV) Drug Exposure
Sponsor: GlaxoSmithKline
Active, not recruiting - verified March 2010
Conditions: Depressive Disorder; Cancer
Interventions: Drug: Regular bupropion use; Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use; Drug: Regular use of any other antidepressant; Drug: Regular TCA (Tricyclic antidepressants) use
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Hypertension
Intervention: Drug: Nebilet
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Breast Cancer
Intervention: Drug: Trastuzumab or Lapatinib
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Leukaemia, Lymphocytic, Chronic
Intervention: Drug: ofatumumab 100 mg, 1000 mg / vial
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Conditions: Lymphoma, Follicular; Lymphoma, Non-Hodgkin
Interventions: Drug: Ofatumumab and Bendamustine infusions (Arm A); Drug: Bendamustine infusion (Arm B)
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: Matching placebo; Drug: Otelixizumab
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Healthy Female Volunteers
Interventions: Biological: albiglutide; Drug: Oral contraceptive
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Intermittent, sub-chronic and chronic Flixonase use; Drug: Intermittent, sub-chronic and chronic use of intranasal steroids other than Flixonase
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Dental Pain
Interventions: Drug: Monographed toothpaste; Device: Occlusion Product 2; Device: Placebo; Other: Occlusion Product 1
Sponsor: GlaxoSmithKline
Completed - verified February 2010
Condition: Post-surgical Dental Pain
Interventions: Drug: Placebo; Drug: Paracetamol 1000 mg; Drug: Paracetamol 500 mg
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Gingivitis
Interventions: Drug: Marketed toothpaste; Drug: Experimental toothpaste
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Acute Otitis Media
Intervention: Procedure: Sample Collection
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Macular Degeneration
Interventions: Drug: pazopanib; Drug: pazopanib; Drug: pazopanib; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Asthma
Intervention: Drug: GSK2239633
Sponsor: GlaxoSmithKline
Completed - verified March 2010
All Categories ... Pharma Companies » ... GlaxoSmithKline 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
